Chugai Pharmabody Research
Nasa Savory is a Senior Principal Scientist at Chugai Pharmabody Research since October 2020, with prior experience as a Principal Scientist at Chugai Pharmaceutical Co., Ltd. from April 2015 to September 2020. Nasa's expertise encompasses antibody engineering and antibody libraries. Academic qualifications include a PhD in Biotechnology and Life Science from Tokyo University of Agriculture and Technology (2012-2014), a Master of Engineering from the same institution (2010-2012), and a Bachelor of Engineering (2006-2010) from Tokyo University of Agriculture and Technology. Nasa also pursued advanced studies at the University of Brighton in both 2010 and 2013. Currently, Nasa is undertaking a Master of Business Administration at the Manning School of Business, UMass Lowell from December 2023 to July 2025.
This person is not in any offices
Chugai Pharmabody Research
1 followers
In the global medical field, there are many diseases in which there are no drug or current drugs are insufficient to address the medical needs of patients. Chugai Pharmabody Research (CPR) is a subsidiary company of Chugai Pharmaceutical in Japan, a member of Roche group, and is committed to address these unmet needs by specializing in the field of antibody drug discovery utilizing proprietary antibody engineering technologies.